Rosuvastatin Withdrawn Phase 4 Trials for Diabetes Mellitus (DM) / Glaucoma Basic Science

IndicationsStatusPurposePhase
WithdrawnBasic Science4
clinicaltrials.gov IdentifierTitleDrugs
NCT00913562Effect of Rosuvastatin on Endothelial Function in Patients With Diabetes and Glaucoma